PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 121 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $48,000 | -15.8% | 20,175 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $57,000 | -23.0% | 20,175 | -21.3% | 0.00% | -33.3% |
| Q1 2022 | $74,000 | -5.1% | 25,636 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $78,000 | -43.5% | 25,688 | +30.8% | 0.00% | -40.0% |
| Q3 2021 | $138,000 | -44.1% | 19,635 | -26.9% | 0.01% | -44.4% |
| Q2 2021 | $247,000 | +118.6% | 26,870 | +130.6% | 0.01% | +125.0% |
| Q1 2021 | $113,000 | -19.9% | 11,652 | -15.1% | 0.00% | -33.3% |
| Q4 2020 | $141,000 | – | 13,717 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |